Calithera Biosciences, Inc. (CALA)
Sector: Biotechnology
Industry: Biotechnology
Calithera Biosciences, Inc.
OTC:CALAHealthcare · Biotechnology
CLOSED
Mkt Cap$487
EV-
Float4.83M
O/S4.87M
VOL345 sh
$ Vol$0
RVOL0.31×
Inst Own-
SI0.1%
Net Cash/Sh-
EarningsNov 17 · Today
Dilution
MCap$487Float4.83MO/S4.87M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 0.0003 | 0.0003 | 0.0003 | 0.0003 | 2,286 |
| Nov 11, 2026 | 0.0003 | 0.0003 | 0.0003 | 0.0003 | 506 |
| Nov 5, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 343 |
| Nov 3, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 190 |
| Oct 28, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,941 |
| Oct 23, 2026 | 0.0003 | 0.0003 | 0.0003 | 0.0003 | 347 |
| Oct 21, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,245 |
| Oct 16, 2026 | 0.0005 | 0.0005 | 0.0000 | 0.0000 | 345 |
| Oct 15, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,143 |
| Oct 14, 2026 | 0.0003 | 0.0003 | 0.0003 | 0.0003 | 100 |
| Oct 13, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 201 |
| Oct 7, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 100 |
| Oct 5, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,042 |
| Oct 2, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 307 |
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not availableRatings Distribution
BUY6
HOLD4
SELL0
TOTAL10
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
0.0%
Institutional
(0)
0.0%
Insiderⓘ
(0)
0.0%
5%+ Owners
(0)
100.0%
Unattributed (incl. retail)ⓘ
Unattributed (incl. retail)100.0%
Sources: 13D/13GO/S: 4.9M · checked 8 Oct 2026 · market-data provider
About
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Key Metrics
Market Cap$487
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
SectorHealthcare
IndustryBiotechnology
ExchangeOTC
Country
US
IPO DateOct 2, 2014
Shares Outstanding4.87M
Authorized Shares
Float4.83M
52-Week Range
Volume
Average Daily Volume1.12K
30d Avg
1.12K
60d Avg
720
90d Avg
743
Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...